Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated 16 min ago
PreprintAll rights reservedbioRxiv

Lipid-ASO therapeutics exhibit differential tissue targeted delivery upon systemic or local CNS administration

5 more authors
  1. 1Karolinska Institutet

Related

  1. Oligonucleotide and RNA-targeted therapeutics for chronic hepatitis B: Antigen reduction, delivery, and functional cure strategies
    Xingchen Meng, Faisal Mahmood, Hui Li +1
    Molecular Therapy: Nucleic AcidsPeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthDOAJEurope PMCEurope PMCPMC
  2. Paclitaxel-induced neuroinflammation after systemic administration in male and female mice
    Martial Caillaud, Yogesh Rakholia, Lauren Soleo +6
    The Journal of PainPeer-reviewedLicence not stated4 citedOncologyHAL
  3. Association of Complete Blood Count Parameters and Systemic Inflammatory Indices with Early Surfactant Administration in Preterm Infants
    Saime Sundus Uygun, Nihal Comez, Osman Selcuk Duysak +3
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Reimagining Antimicrobial Drug Delivery: Spatiotemporally Adaptive Therapeutics for Biofilm-Associated Infections and Antimicrobial Resistance.
    Eman Marzouk, Mahmoud Jaber
    PharmaceuticsPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  5. Timing of First Systemic Antibiotic Administration and Risk of Deep Infection in Adults with Open Long-Bone Fractures: A Systematic Review and Threshold-Specific Evidence Synthesis
    Nguyen The Diep, Nguyen Minh Chau, Phan Thanh Nam +1
    Journal of clinical medicinePeer-reviewedCC BYFull textEpidemiology & public healthEurope PMCCrossref
BibTeX
@misc{roudi2026lipidaso,
  title = {{Lipid-ASO therapeutics exhibit differential tissue targeted delivery upon systemic or local CNS administration}},
  author = {S. Roudi and H. Y. Estupinan and O. Saher and C. Barradas and E. Inganas and H.-N. Le and N. Frengen and R. Grochowski and S. Pavlova and R. Mansson Welinder and J. Z. Nordin and A. Biscans and P. Matsson and R. Zain and R. Sandberg and M. Hagemann-Jensen and S. EL Andaloussi},
  howpublished = {bioRxiv},
  year = {2026},
  month = aug,
  doi = {10.64898/2026.08.28.747711},
  url = {https://www.biorxiv.org/content/10.64898/2026.08.28.747711v1},
}
RIS
TY  - UNPB
TI  - Lipid-ASO therapeutics exhibit differential tissue targeted delivery upon systemic or local CNS administration
AU  - S. Roudi
AU  - H. Y. Estupinan
AU  - O. Saher
AU  - C. Barradas
AU  - E. Inganas
AU  - H.-N. Le
AU  - N. Frengen
AU  - R. Grochowski
AU  - S. Pavlova
AU  - R. Mansson Welinder
AU  - J. Z. Nordin
AU  - A. Biscans
AU  - P. Matsson
AU  - R. Zain
AU  - R. Sandberg
AU  - M. Hagemann-Jensen
AU  - S. EL Andaloussi
PY  - 2026
DA  - 2026/08/28
PB  - bioRxiv
DO  - 10.64898/2026.08.28.747711
UR  - https://www.biorxiv.org/content/10.64898/2026.08.28.747711v1
ER  -